<s>
Erythropoietin_NN1 ,_, which_DDQ is_VBZ commonly_RR known_VVN as_II EPO_NP1 ,_, is_VBZ a_AT1 glycoprotein_NN1 hormone_NN1 produced_VVD naturally_RR in_II the_AT kidney_NN1 ;_; it_PPH1 is_VBZ the_AT hormone_NN1 that_CST regulates_VVZ the_AT production_NN1 of_IO erythrocytes_NN2 typically_RR known_VVN as_II red_JJ blood_NN1 cells_NN2 ._. 
</s>
<s>
It_PPH1 consists_VVZ of_IO 165_MC amino_NN1 acids_NN2 ,_, with_IW four_MC oligosaccharide_NN1 side_NN1 chains_NN2 attached_VVN ._. 
</s>
<s>
It_PPH1 is_VBZ found_VVN mainly_RR in_II bone_NN1 marrow_NN1 where_CS it_PPH1 acts_VVZ as_II a_AT1 cytokine_NN1 to_TO increase_VVI the_AT production_NN1 of_IO erythrocytes_NN2 ._. 
</s>
<s>
An_AT1 increase_NN1 in_II red_JJ blood_NN1 cells_NN2 increases_VVZ the_AT amount_NN1 of_IO oxygen_NN1 that_CST the_AT blood_NN1 can_VM carry_VVI ;_; it_PPH1 can_VM also_RR improve_VVI the_AT body_NN1 's_GE capacity_NN1 to_TO buffer_VVI lactic_JJ acid_NN1 ,_, which_DDQ is_VBZ the_AT waste_NN1 product_NN1 from_II anaerobic_JJ respiration_NN1 ._. 
</s>
<s>
Stimuli_NN2 such_II21 as_II22 bleeding_VVG or_CC movement_NN1 to_II a_AT1 higher_JJR altitude_NN1 trigger_NN1 the_AT body_NN1 to_TO release_VVI EPO_NN1 into_II the_AT bloodstream_NN1 ._. 
</s>
<s>
The_AT process_NN1 of_IO regulating_VVG a_AT1 stable_JJ constant_JJ concentration_NN1 of_IO oxygen_NN1 within_II the_AT blood_NN1 is_VBZ a_AT1 form_NN1 of_IO homeostasis_NN1 ._. 
</s>
<s>
Normally_RR EPO_NP1 is_VBZ found_VVN at_II very_RG low_JJ concentrations_NN2 in_II the_AT blood_NN1 plasma_NN1 (_( 5_MC mol/L_FU )_) ,_, but_CCB if_CS around_II the_AT pertituber_NN1 cells_NN2 in_II the_AT kidney_NN1 where_CS EPO_NP1 is_VBZ mainly_RR formed_VVN a_AT1 low_JJ oxygen_NN1 blood_NN1 content_NN1 is_VBZ detected_VVN ,_, a_AT1 condition_NN1 known_VVN as_II hypoxia_NN1 ,_, EPO_NP1 is_VBZ released_VVN increasing_VVG this_DD1 concentration_NN1 in_II the_AT bloodstream_NN1 ._. 
</s>
<s>
When_CS EPO_NP1 is_VBZ released_VVN it_PPH1 acts_VVZ by_II binding_VVG to_II a_AT1 specific_JJ receptor_NN1 (_( EpoR_NP1 )_) found_VVD on_II the_AT surface_NN1 of_IO red_JJ blood_NN1 cell_NN1 precursors_NN2 in_II the_AT bone_NN1 marrow_NN1 ,_, this_DD1 causes_VVZ them_PPHO2 to_TO convert_VVI into_II mature_JJ red_JJ blood_NN1 cells_NN2 ._. 
</s>
<s>
The_AT oxygen_NN1 content_NN1 of_IO the_AT blood_NN1 is_VBZ therefore_RR increased_VVN and_CC so_RR this_DD1 causes_VVZ a_AT1 decrease_NN1 in_II the_AT release_NN1 of_IO EPO_NP1 ,_, and_CC homeostasis_NN1 is_VBZ maintained_VVN ._. 
</s>
<s>
The_AT introduction_NN1 of_IO recombinant_JJ EPO_NN1 can_VM have_VHI a_AT1 major_JJ therapeutic_JJ benefit_NN1 to_II sufferers_NN2 of_IO conditions_NN2 such_II21 as_II22 chronic_JJ kidney_NN1 disease_NN1 that_CST normally_RR results_VVZ in_II an_AT1 EPO_NN1 deficiency_NN1 ,_, which_DDQ can_VM then_RT lead_VVI onto_II anemia_NN1 ._. 
</s>
<s>
Anemia_NN1 may_VM also_RR occur_VVI in_II cancer_NN1 patients_NN2 as_II a_AT1 consequence_NN1 of_IO the_AT disease_NN1 or_CC as_II an_AT1 adverse_JJ effect_NN1 from_II the_AT chemotherapy_NN1 treatment_NN1 they_PPHS2 receive_VV0 ._. 
</s>
<s>
It_PPH1 is_VBZ also_RR used_VVN as_II an_AT1 alternative_NN1 for_IF patients_NN2 who_PNQS require_VV0 a_AT1 blood_NN1 transfusion_NN1 or_CC before_II surgery_NN1 when_CS a_AT1 loss_NN1 of_IO blood_NN1 is_VBZ expected_VVN ._. 
</s>
<s>
The_AT bone_NN1 marrow_NN1 produces_VVZ more_RGR red_JJ blood_NN1 cells_NN2 so_RR even_CS21 if_CS22 a_AT1 loss_NN1 of_IO blood_NN1 is_VBZ experienced_VVN there_RL is_VBZ still_RR enough_RR to_TO prevent_VVI the_AT patient_NN1 from_II dieing_VVG ._. 
</s>
<s>
Recombinant_JJ EPO_NN1 has_VHZ played_VVN a_AT1 major_JJ role_NN1 in_II the_AT treatment_NN1 of_IO many_DA2 anemia_NN1 patients_NN2 ,_, but_CCB also_RR since_CS its_APPGE pharmaceutical_JJ release_NN1 in_II the_AT late_JJ 1980_MC221% 's_MC222% it_PPH1 has_VHZ been_VBN used_VVN as_II a_AT1 blood_NN1 doping_NN1 agent_NN1 ._. 
</s>
<s>
Endurance_NN1 athletes_NN2 such_II21 as_II22 cyclists_NN2 especially_RR those_DD2 who_PNQS compete_VV0 in_II multi-stage_JJ races_NN2 such_II21 as_II22 the_AT Tour_FW de_FW France_NP1 can_VM benefit_VVI from_II increased_JJ amounts_NN2 of_IO EPO_NN1 as_CSA it_PPH1 can_VM delay_VVI the_AT decrease_NN1 in_II red_JJ blood_NN1 cell_NN1 count_VV0 that_CST occurs_VVZ during_II long_JJ periods_NN2 of_IO racing_VVG and_CC so_RR minimise_VV0 fatigue_NN1 ._. 
</s>
<s>
Other_JJ long_JJ distance_NN1 athletes_NN2 can_VM also_RR benefit_VVI from_II an_AT1 increase_NN1 in_II EPO_NP1 as_CSA it_PPH1 increases_VVZ the_AT oxygen_NN1 carrying_NN1 capacity_NN1 of_IO the_AT blood_NN1 ,_, the_AT hematocrit_NN1 level_NN1 ;_; this_DD1 then_RT increases_VVZ the_AT aerobic_JJ respiratory_JJ capacity_NN1 of_IO the_AT athletes_NN2 muscles_NN2 ,_, allowing_VVG them_PPHO2 to_TO compete_VVI for_IF longer_JJR and_CC so_RR have_VH0 a_AT1 greater_JJR stamina_NN1 ._. 
</s>
<s>
As_CSA EPO_NP1 is_VBZ naturally_RR produced_VVN by_II the_AT body_NN1 it_PPH1 is_VBZ hard_JJ to_TO detect_VVI ,_, and_CC when_CS it_PPH1 was_VBDZ made_VVN available_JJ in_II the_AT late_JJ 1980_MC221% 's_MC222% there_EX was_VBDZ no_AT way_NN1 to_TO detect_VVI its_APPGE presence_NN1 except_CS if_CS an_AT1 athlete_NN1 was_VBDZ caught_VVN in_II possession_NN1 ._. 
</s>
<s>
But_CCB there_EX are_VBR a_AT1 number_NN1 of_IO side_NN1 effects_NN2 that_CST a_AT1 number_NN1 of_IO cyclists_NN2 at_II the_AT time_NNT1 started_VVD to_TO display_VVI ,_, such_II21 as_II22 nose_NN1 bleeds_VVZ caused_VVN by_II a_AT1 thickening_NN1 of_IO the_AT blood_NN1 as_CSA it_PPH1 contains_VVZ a_AT1 larger_JJR number_NN1 of_IO erythrocytes_NN2 ,_, this_DD1 causes_VVZ difficulty_NN1 in_II its_APPGE passage_NN1 through_II thin_JJ capillaries_NN2 ._. 
</s>
<s>
A_AT1 slower_JJR resting_NN1 heart_NN1 rate_NN1 and_CC a_AT1 decreased_JJ white_JJ blood_NN1 cell_NN1 count_VV0 that_CST leads_VVZ onto_II a_AT1 suppressed_JJ immune_JJ system_NN1 ._. 
</s>
<s>
The_AT International_JJ Olympic_JJ committee_NN1 (_( IOC_NP1 )_) issued_VVD its_APPGE first_MD list_NN1 of_IO substances_NN2 that_CST are_VBR banned_VVN from_II use_NN1 by_II athletes_NN2 in_II 1967_MC ,_, and_CC began_VVD drug_NN1 testing_NN1 of_IO athletes_NN2 in_II the_AT 1968_MC Olympics_NN2 ._. 
</s>
<s>
From_II this_DD1 Olympics_VVZ the_AT committee_NN1 has_VHZ required_VVN cities_NN2 hosting_VVG the_AT Olympic_JJ Games_NN2 to_TO provide_VVI adequate_JJ facilities_NN2 in_II which_DDQ drug_NN1 testing_NN1 can_VM take_VVI place_NN1 ._. 
</s>
<s>
The_AT World_NN1 anti-doping_JJ agency_NN1 (_( WADA_NP1 )_) not_XX finished_VVN !_! !_! !_! ._. 
</s>
<s>
EPO_NP1 has_VHZ been_VBN banned_VVN since_CS the_AT early_JJ 1900_MC 's_GE and_CC a_AT1 detection_NN1 method_NN1 for_IF its_APPGE presence_NN1 has_VHZ been_VBN in_II force_NN1 since_II 2000_MC ._. 
</s>
<s>
Scientists_NN2 from_II the_AT French_JJ national_JJ anti-doping_JJ laboratory_NN1 ,_, endorsed_VVN by_II the_AT WADA_NN1 ,_, developed_VVD a_AT1 test_NN1 to_TO separately_RR detect_VVI pharmaceutical_JJ recombinant_JJ EPO_NN1 from_II its_APPGE nearly_RR identical_JJ natural_JJ form_NN1 of_IO the_AT hormone_NN1 ,_, this_DD1 has_VHZ been_VBN made_VVN achievable_JJ as_II the_AT available_JJ brands_NN2 of_IO EPO_NP1 are_VBR made_VVN within_II cultured_JJ animal_NN1 cells_NN2 ,_, causing_VVG them_PPHO2 to_TO have_VHI a_AT1 different_JJ pattern_NN1 of_IO oligosaccharide_NN1 residues_NN2 meaning_VVG in_II theory_NN1 the_AT different_JJ forms_NN2 can_VM be_VBI easily_RR distinguished_VVN from_II each_PPX221 other_PPX222 ._. 
</s>
<s>
But_CCB this_DD1 method_NN1 has_VHZ come_VVN under_II serious_JJ criticism_NN1 in_II its_APPGE ability_NN1 to_TO separate_VVI pharmaceutical_JJ EPO_NN1 from_II the_AT naturally_RR occurring_VVG form_NN1 usually_RR found_VVN in_II an_AT1 athlete_NN1 's_GE urine_NN1 after_II strenuous_JJ exercise_NN1 ._. 
</s>
<s>
The_AT testing_NN1 relies_VVZ on_II techniques_NN2 such_II21 as_II22 gel_NN1 electrophoresis_NN1 more_RGR specifically_RR the_AT Western_JJ blot_NN1 technique_NN1 and_CC isoelectric_JJ focusing_NN1% ._. 
</s>
<s>
But_CCB before_CS this_DD1 can_VM be_VBI conducted_VVN the_AT urine_NN1 sample_NN1 must_VM be_VBI collected_VVN ,_, this_DD1 is_VBZ achieved_VVN by_II following_VVG well_RR defined_VVN and_CC tested_VVN procedures_NN2 which_DDQ ensures_VVZ the_AT privacy_NN1 of_IO the_AT individual_NN1 ,_, sterile_JJ equipment_NN1 and_CC protective_JJ clothing_NN1 are_VBR used_VVN in_BCL21 order_BCL22 to_TO prevent_VVI cross_NN1 contamination_NN1 ._. 
</s>
<s>
Chain_NN1 of_IO Custody_NN1 documentation_NN1 is_VBZ also_RR written_VVN which_DDQ details_VVZ% the_AT sample_NN1 's_GE pathway_NN1 from_II the_AT individual_NN1 to_II the_AT analyst_NN1 in_BCL21 order_BCL22 to_TO avoid_VVI legal_JJ action_NN1 ._. 
</s>
<s>
Two_MC samples_NN2 are_VBR taken_VVN labeled_JJ sample_NN1 "_" A_ZZ1 "_" and_CC sample_NN1 "_" B_ZZ1 "_" ,_, sample_NN1 "_" A_ZZ1 "_" is_VBZ analysed_VVN straightaway_RR and_CC sample_NN1 "_" B_ZZ1 "_" is_VBZ frozen_VVN and_CC stored_VVN ._. 
</s>
<s>
Sample_VV0 "_" B_ZZ1 "_" is_VBZ only_RR tested_VVN on_RP if_CS sample_NN1 "_" A_ZZ1 "_" produces_VVZ a_AT1 positive_JJ result_NN1 ._. 
</s>
<s>
The_AT laboratories_NN2 that_CST perform_VV0 this_DD1 testing_NN1 must_VM have_VHI been_VBN accredited_VVN to_II the_AT ISO_NP1 17025_MC standard_JJ ._. 
</s>
<s>
Before_CS the_AT samples_NN2 are_VBR analysed_VVN they_PPHS2 firstly_RR need_VV0 to_TO be_VBI prepared_VVN ,_, this_DD1 involves_VVZ a_AT1 long_JJ sequence_NN1 of_IO events_NN2 ._. 
</s>
<s>
The_AT sample_NN1 is_VBZ firstly_RR rapidly_RR cooled_VVN or_CC frozen_JJ ,_, and_CC then_RT homogenized_VVD this_DD1 can_VM be_VBI achieved_VVN in_II various_JJ ways_NN2 such_II21 as_II22 sonication_NN1 this_DD1 is_VBZ applying_VVG energy_NN1 in_II the_AT form_NN1 of_IO sound_NN1 usually_RR ultrasound_VV0 to_TO break_VVI up_RP the_AT sample_NN1 ,_, or_CC by_II applying_VVG a_AT1 mechanical_JJ force_NN1 ,_, or_CC finally_RR by_II causing_VVG the_AT cells_NN2 to_TO be_VBI lysed_VVN (_( destroyed_VVN )_) using_VVG high_JJ salt_NN1 buffers_NN2 (_( 150mM_NNU )_) ._. 
</s>
<s>
The_AT produced_JJ% homogenate_NN1 ,_, which_DDQ contains_VVZ the_AT whole_JJ cell_NN1 ,_, can_VM then_RT be_VBI analysed_VVN ,_, or_CC broken_VVN down_RP further_RRR by_II centrifugation_NN1 to_TO isolate_VVI different_JJ parts_NN2 of_IO the_AT cells_NN2 ._. 
</s>
<s>
The_AT sample_NN1 is_VBZ then_RT boiled_VVN in_II a_AT1 buffer_NN1 solution_NN1 for_IF up_RG21 to_RG22 five_MC minutes_NNT2 ,_, the_AT buffer_NN1 solution_NN1 normally_RR contains_VVZ a_AT1 mixture_NN1 of_IO beta-mercaptoethanol_NN1 ,_, a_AT1 type_NN1 of_IO anionic_JJ lipholic_JJ detergent_NN1 called_VVN Sodium_NN1 dodecyl_NN1 sulfate_NN1 (_( SDS_NP1 )_) and_CC glycerol_NN1 ._. 
</s>
<s>
The_AT boiling_JJ causes_NN2 the_AT protein_NN1 to_TO denature_VVI and_CC unfold_VVI completely_RR ;_; the_AT SDS_NP1 then_RT coats_NN2 the_AT sample_NN1 with_IW a_AT1 negative_JJ charge_NN1 and_CC the_AT beta-mercaptoethanol_NN1 prevents_VVZ any_DD sulfide_NN1 bridges_NN2 from_II being_VBG reformed_VVN and_CC lastly_RR the_AT glycol_NN1 's_GE purpose_NN1 is_VBZ to_TO add_VVI density_NN1 to_II the_AT sample_NN1 ._. 
</s>
<s>
The_AT sample_NN1 can_VM then_RT be_VBI placed_VVN into_II a_AT1 well_NN1 in_II the_AT Polyacrylamide_NN1 gel_NN1 ;_; the_AT added_JJ density_NN1 causes_VVZ the_AT sample_NN1 to_TO fall_VVI to_II the_AT bottom_NN1 of_IO the_AT well_NN1 ._. 
</s>
<s>
Electrophoresis_NN1 is_VBZ the_AT migration_NN1 of_IO a_AT1 charged_JJ particle_NN1 in_II an_AT1 electrical_JJ field_NN1 ,_, the_AT technique_NN1 works_VVZ as_RG different_JJ solutes_NN2 move_VV0 at_II different_JJ velocities_NN2 depending_II21 on_II22 their_APPGE mass_NN1 and_CC charge_NN1 ._. 
</s>
<s>
Small_NP1 and_CC highly_RR charges_NN2 species_NN have_VH0 a_AT1 high_JJ mobility_NN1 and_CC heavy_JJ and_CC minimally_RR charged_VVN species_NN have_VH0 low_JJ mobility_NN1 through_II the_AT electrical_JJ field_NN1 ._. 
</s>
<s>
Isoelectric_JJ focusing_NN1% is_VBZ a_AT1 type_NN1 of_IO electrophoresis_NN1 that_CST involves_VVZ the_AT separation_NN1 of_IO amphoteric_JJ sample_NN1 components_NN2 in_II a_AT1 pH_NN1 gradient_NN1 ._. 
</s>
<s>
Firstly_RR a_AT1 pH_NN1 gradient_NN1 is_VBZ set_VVN up_RP involving_VVG an_AT1 anode_NN1 (_( low_JJ pH_NN1 )_) and_CC a_AT1 cathode_NN1 (_( high_JJ pH_NN1 )_) ,_, an_AT1 electric_JJ field_NN1 is_VBZ then_RT applied_VVN which_DDQ causes_VVZ the_AT amphoteric_JJ components_NN2 to_TO migrate_VVI ._. 
</s>
<s>
The_AT negative_JJ charged_JJ components_NN2 move_VV0 toward_II the_AT positive_JJ anode_NN1 and_CC the_AT positively_RR charged_VVN components_NN2 move_VV0 toward_II the_AT cathode_NN1 ._. 
</s>
<s>
If_CS we_PPIS2 consider_VV0 the_AT net_JJ negative_JJ charge_NN1 movement_NN1 ,_, the_AT migration_NN1 encounters_VVZ a_AT1 decrease_NN1 in_II the_AT pH_NN1 of_IO its_APPGE surroundings_NN2 ,_, and_CC therefore_RR becomes_VVZ protonated_JJ ._. 
</s>
<s>
Eventually_RR a_AT1 pH_NN1 is_VBZ encountered_VVN where_CS its_APPGE net_JJ charge_NN1 is_VBZ equal_JJ to_II a_AT1 position_NN1 known_VVN as_II the_AT isoelectric_JJ point_NN1 ,_, at_II this_DD1 point_NN1 the_AT migration_NN1 ceases_VVZ ._. 
</s>
<s>
Each_DD1 component_NN1 in_II the_AT sample_NN1 moves_VVZ to_II its_APPGE respective_JJ isoelectric_JJ point_NN1 and_CC stops_VVZ moving_VVG ,_, the_AT isoelectric_JJ points_NN2 may_VM occur_VVI over_II the_AT whole_JJ pH_NN1 range_NN1 ._. 
</s>
<s>
The_AT electrophoresis_NN1 is_VBZ carried_VVN out_RP in_II a_AT1 Polyacrylamide_NN1 gel_NN1 ,_, gels_NN2 such_II21 as_II22 this_DD1 act_NN1 as_CSA anticonvection_NN1 stabilisers_NN2 ,_, these_DD2 lower_VV0 the_AT thermally_RR driven_JJ convection_NN1 currents_NN2 that_CST occur_VV0 in_II the_AT elecrophoretic_JJ medium_NN1 ._. 
</s>
<s>
They_PPHS2 also_RR create_VV0 permanent_JJ pH_NN1 gradients_NN2 by_II binding_VVG together_RL specific_JJ groups_NN2 within_II the_AT gel_NN1 ._. 
</s>
<s>
Polyacrylamide_VV0 gels_NN2 are_VBR prepared_VVN by_II polymerisation_NN1 of_IO acrylamide_NN1 using_VVG N_ZZ1 ,_, N'-Methylene-bis-acrylamide_FU as_II a_AT1 cross_NN1 linker_NN1 ,_, and_CC ammonium_NN1 persulfate_NN1 as_II an_AT1 initiator_NN1 :_: -_- ._. 
</s>
<s>
The_AT sample_NN1 is_VBZ placed_VVN into_II a_AT1 well_NN1 formed_VVN in_II the_AT gel_NN1 next_II21 to_II22 which_DDQ another_DD1 well_NN1 is_VBZ prepared_VVN which_DDQ contains_VVZ pharmaceutical_JJ EPO_NN1 that_CST acts_VVZ as_II a_AT1 reference_NN1 to_II which_DDQ the_AT sample_NN1 can_VM be_VBI compared_VVN ._. 
</s>
<s>
The_AT proteins_NN2 must_VM be_VBI transferred_VVN onto_II a_AT1 Nitrocellulose_NN1 membrane_NN1 in_BCL21 order_BCL22 for_IF them_PPHO2 to_TO be_VBI made_VVN antibody_NN1 accessible_JJ ,_, this_DD1 is_VBZ achieved_VVN by_II placing_VVG the_AT membrane_NN1 right_NN1 next_II21 to_II22 the_AT gel_NN1 and_CC applying_VVG a_AT1 current_JJ via_II plates_NN2 placed_VVN on_II the_AT gel_NN1 and_CC membrane_NN1 ._. 
</s>
<s>
This_DD1 causes_VVZ the_AT charged_JJ particles_NN2 to_TO move_VVI from_II the_AT gel_NN1 onto_II the_AT membrane_NN1 producing_VVG a_AT1 copy_NN1 of_IO the_AT pattern_NN1 formed_VVN on_II the_AT gel_NN1 ,_, this_DD1 process_NN1 is_VBZ termed_VVN "_" blotting_VVG "_" ._. 
</s>
<s>
Nitrocellulose_NN1 binds_VVZ to_II all_DB types_NN2 of_IO protein_NN1 ,_, it_PPH1 is_VBZ non-specific_JJ ,_, but_CCB because_II21 of_II22 this_DD1 the_AT membrane_NN1 has_VHZ to_TO be_VBI placed_VVN into_II a_AT1 milk_NN1 protein_NN1 solution_NN1 ,_, which_DDQ prevents_VVZ binding_VVG between_II the_AT membrane_NN1 and_CC the_AT antibody_NN1 used_VVN for_IF the_AT probing_JJ of_IO specific_JJ proteins_NN2 from_II occurring_VVG ._. 
</s>
